PFIZERPfizer Limited
Pharma · Drug Manufacturers - General · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
Why avoid
- • Overall evidence is weak (AlgoScore 40/100)
- • Revenue growth: 6.3% YoY
- • Profit growth: -39.6% YoY
- • RSI: 35
- • Price vs EMA21: below
- • Double Top bearish signal (setup quality 63%)
Bull case
- • ROE: 17.2%
- • ROCE: 19.8%
- • Debt/Equity: 0.02
- • MACD: bullish
Bear case
- • Revenue growth: 6.3% YoY
- • Profit growth: -39.6% YoY
- • RSI: 35
- • Price vs EMA21: below
Key risks
- • Momentum is fading versus the broader market
- • Revenue growth: 6.3% YoY
- • Profit growth: -39.6% YoY
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹98.54). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.